← Eichor
Study identifier: NCT07602023 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Risk of Progression Towards DIABETES and Development of Complications. LIPINFAT Diabetes Study.

Condition: Prediabetes / Type 2 Diabetes  ·  Sponsor: Angelina Passaro

PhaseN/A
Planned participants150
Who can joinAll sexes, 50 Years to 70 Years
Healthy volunteersNo

About this study

The aim of the study is to evaluate whether the Oral Fat Loading Test (OFLT) determines a different response in terms of the quantity, quality, and kinetics of triglyceride-rich lipoproteins in subjects with T2D, prediabetics, and control subjects, and whether triglyceride-rich lipoproteins and inflammatory cytokines after OFLT are potential early biomarkers of the risk of progression to diabetes and the development of complications in a general practice setting. To address these questions, a hybrid cohort study was designed by identifying three groups of subjects: T2D and prediabetics (exposed and near-exposed) and control subjects (unexposed).

This description comes directly from the study's public registry record.

Talk to the study team

Fabiola Castaldo, Pharmacy  ·  +39 3348330516  ·  fabiola.castaldo@unife.it

Juana M Sanz Molina, Chemistry  ·  szj@unife.it

Always discuss trial participation with your own doctor first.

Locations (2)

University Hospital "Sant'Anna" of FerraraFerrara, Ferrara, ItalyRecruiting
Nucleo di Cure Primarie di Poggio Renatico - Medicina di Gruppo Poggio Rete Salute Via Salvo D'Acquisto, 1/aPoggio Renatico, Ferrara, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07602023